Institut Paoli Calmettes — Clinical Trial Site

460 Registered trials

210 Currently recruiting

Organisation

Institut Paoli Calmettes

Location

Marseille, France

Identifier

ORG-100009600

Address

232 Boulevard De Sainte Marguerite, Bp 156, 13009, France

Departments

-
/
#:9003 Medical Oncology
#1504: Medical Oncology and Molecular Pharmacology
#1700: Oncology
#2000:Hematologie 4
#2023: Department of Hematology
#6001: Hematologie
1011: Nephrologie et transplantation rénale
102: Oncologie Medicale - Cancerolo
105: Hôpital de jour
1201: Oncologie Médicale
1202 Medical Oncology
1208: Oncologie Medicale
125007
13
1402: Medical Oncology
1508:Medical Oncology
1703:Medical Oncology
2312 Oncology Medical
2403: Hématologie
3003: Medical Oncology
403: Hôpital de jour
6003:Hematology
7002: Medical Oncology
Bouches du Rhône
Bouches-du-Rhône
Chirurgie
Chirurgie Digestive
Chirurgie gynécologique
Chirurgie oncologique
Chirurgie Oncologique Gynécologique
Clinical Haematology
Clinical Hematology Unit
Département d'hématologie
Departement d'Oncologie Medicale
Département D’Hématologie
Département d’Onco-Hématologie
département d’Oncologie
Département d’Oncologie médicale
Département de la Recherche Clinique et de l’Innovation - Unite Investigation
Departement Hematologie
Departement of Medical Oncology
Département ONCO Médical 1
Département onco-hématologie
Department Medical Oncology
Department of Hematology
Department of medical oncology
Dept d'Oncologie Medicale
Digestive and surgical oncology
DRCI
DRCI - ui - IPC5
Early Phase Clinical Study Unit
FR033A: Hematologie
FR10012: Hematologie 1
Gynecological surgery
Haematology
Hématologie
Hematologie 1
Hématologie 2
Hématologie et Transplantation
Hématologie IPC4
Hematology
Hematology departement
Hematology Department
HGE
Hopital de jour médical/Unité d’Evaluation Thérapeutique en Onco-Hématologie (EOTH)
Institut du Thorax
Institut Paoli-Calmettes
IPC
Medecine nucleaire
medecine nuclear department
Medical and Surgical ICU
Medical Oncology
Medical Oncology Department
N/A
NA
NAP
onco
Onco-hématologie
Onco-Hematology Department
Onco-Hematology Therapeutic Evaluation Unit
Oncologie
Oncologie digestive
Oncologie Médical
Oncologie médicale
Oncologie sein
Oncologue
Oncology
Oncology Department
Oncology surgery
Outpatient Hospital
Outpatient Unit
Pneumology Oncology
Pneumonology
Pôle Hématologie
Radiology
Radiothérapie
Radiotherapy
Reanimation
Service d'hématologie
Service d'hématologie seniors
Service d'Oncologie
Service d'oncologie digestive
Service d'Oncologie Médicale
Service d'Oncologie médicale 1
Service d‘hématologie
Service d‘Onco-Hématologie
Service d’hématologie
Service d’Oncologie Médicale
Service de Pneumologie
Service hématologie
Service Oncologie
Service Oncologie Médical 1
Service Oncologie Médicale
Services des Maladies Infectieuses
Surgical Oncology 2
Unité ambulatoire (outpatient unit)
Unité d'hématologie
Unité d’Hématologie 3
Unité de jour médical
Unité de Soins Ambulatoires
Unite de Traitement des Leucemies
Unité Fonctionnelle d'Anesthésie
Unités d'hématologie 2 et évaluation thérapeutique en Oncologie/hématologie
Urologie
Urology

Clinical trials at this site (460)

Search interface

Study of axitinib +/- pembrolizumab in first line treatment for patients with locally advanced or metastatic papillary renal cell carcinoma … Recruiting

2024-513986-38-00 Locally advanced or metastatic papillary cell carcinoma 4 2022-06-01
Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas. Recruiting

2024-510706-86-00 Advanced/ metastatic soft tissue sarcomas 9 2022-05-16
PEMBROCABOSARC : Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas Recruiting

2023-509496-16-00 Advanced /metastatic sarcomas: undifferentiated pleomor 4 2022-04-21
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 10 2022-02-03
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
A Study with ABBV-CLS-484 Alone and in Combination in Subjects with Advanced Tumor Cancer Recruiting

2023-507568-38-00 Metastatic or locally advanced tumors 1 2022-01-14
STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE… Recruiting

2024-511001-28-00 Neuroendocrine tumor 4 2021-12-13
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 local advenced pancreatic adenocarcinoma 4 2021-06-17
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Recruiting

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11
A phase II open-label study evaluating valemetostat tosylate as a single agent in patients with relapse/refractory B-cell lymphoma Recruiting

2024-516181-11-00 RELAPSE/REFRACTORY B-CELL LYMPHOMA. 4 2021-06-10
Comparison of Cyclophosphamide and doxorubicin as a first line treatment in elderly patients with metastatic sarcoma Recruiting

2024-510653-10-00 Advanced or metastatic soft tissue sarcoma (STS) in pat 5 2021-06-04
Phase 2, Open label Study of Patritumab Deruxtecan (U3-1402), an Anti-HER3-Antibody Drug Conjugate (ADC), in patients with Advanced Breast C… Recruiting

2023-505923-30-00 Patients with hormone-receptor positive (HR+) and human 4 2021-05-11
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Recruiting

2023-504931-42-00 Chronic lymphocytic leukemia/Small lymphocytic lymphoma 4 2021-04-06
AGADIR : Atezolizumab combined with EIK10001 (BDB001) and Immunogenic Radiotherapy in Patients with Advanced Solid Tumors Recruiting

2023-509492-16-00 Adult participants with metastatic (advanced) solid tum 4 2021-03-30
Randomized phase III trial on NIraparib-Dostarlimab vs physician’s choice CHEmotherapy in recurrent, ovarian, fallopian tube or primary peri… Recruiting

2024-516649-38-00 Recurrent ovarian, fallopian tube or primary peritoneal 5 2020-12-01
GROINSS-V III Recruiting

2023-508722-99-00 Vulvar cancer 4 2020-11-19
Interest of peri operative CHemotherapy In patients with CINSARC highrisk localized Soft Tissue Sarcoma. Recruiting

2024-515384-62-00 Soft Tissue Sarcoma 5 2020-10-09
Clinical trial evaluating the value of treatment with therapy specifically targeting the molecular alterations identified in the tumor of pa… Recruiting

2023-510567-35-00 Advanced / metastatic cancers 4 2020-06-10
Non inferiority study of preoperative chemotherapy without pelvic irradiation for rectal cancer Recruiting

2024-510580-28-00 Middle or low locally advanced resectable rectal carcin 5 2019-06-05
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting

2023-508302-24-00 Locally Advanced/Metastatic Urothelial Cancer 4 2019-05-07
PHASE III TRIAL INVESTIGATING BENEFIT OF INTENSIFIED PERI-OPERATIVE CHEMOTHERAPY WITHIN HIGH-RISK CINSARC PATIENTS WITH RESECTABLE SOFT-TISS… Recruiting

2023-509489-39-00 Resectable, non-metastatic soft-tissue sarcoma (STS) 5 2019-02-05
Trial that evaluates the interest of interruption versus maintaining the treatment of aromatase inhibitors in patients with metastatic low g… Recruiting

2024-512629-97-00 Patients with locally advanced or metastatic low grade 4 2019-01-23
Randomised trial evaluating mifamurtide in combination with standard chemotherapy in patients with high-grade osteosarcoma at high risk of r… Recruiting

2024-514780-26-00 Patients ≤50 years old with high-risk osteosarcoma (def 4 2018-10-23